drugset / Trial / NCT04339985

Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate AD

NCT04339985

Phase 2 Completed 220 enrolled UNION therapeutics
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a Phase 2 randomized, double-blind, parallel group, vehicle-controlled study to evaluate the safety and efficacy of topical ATx201 OINTMENT in adolescents and adults with mild to moderate Atopic Dermatitis

Timeline

Start
2019-10-22
Primary completion
2020-10-22
Completion
2021-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject ATx201 Unknown 4 % Topical
Subject ATx201 Unknown 7 % Topical

Indications